18F-FDG PET/CT in Anti-NMDA Receptor Encephalitis: Typical Pattern and Follow-up

Overview

Journal Clin Nucl Med

Specialty Nuclear Medicine

Date 2018 May 10

PMID 29742610

Citations 8

Authors

Abdenasser Moubtakir

Sebastien Dejust

Francois Godard

Leila Messaoud

David Morland

Affiliations

Soon will be listed here.

Abstract

We report the case of a 28-year-old woman presenting behavior disorders of subacute onset. She was referred in our institution for a suspicion of limbic encephalitis. F-FDG PET/CT did not show any mesiotemporal abnormality but depicted a decreased uptake of bilateral parietal and occipital lobes. This atypical pattern was compatible with an anti-N-methyl-D-aspartate receptor encephalitis that was later confirmed.

Citing Articles

Unusual imaging findings associated with abdominal pediatric germ cell tumors.

Gagnon M, Derenoncourt P, Rayamahi S, Taylor S, Parikh A, Ponisio M Pediatr Radiol. 2024; 54(7):1093-1104.

PMID: 38462578 DOI: 10.1007/s00247-024-05894-9.

Enhancing the clinical diagnosis of the acute and subacute phases of autoimmune encephalitis and predicting the risk factors: the potential advantages of 18F-FDG PET/CT.

Liu L, Lyu Z, Li H, Bai L, Wan Y, Li P BMC Med Imaging. 2023; 23(1):193.

PMID: 37986052 PMC: 10662540. DOI: 10.1186/s12880-023-01148-6.

Typical metabolic pattern of F-FDG PET in Anti-NMDAR encephalitis in the acute and subacute phases and its correlation with T2 FLAIR-MRI features.

Yuan L, Mao G, Zhang Y, Xu Y, Chen Q, Shan B BMC Neurosci. 2023; 24(1):51.

PMID: 37749547 PMC: 10521454. DOI: 10.1186/s12868-023-00823-2.

Usefulness of brain FDG PET/CT imaging in pediatric patients with suspected autoimmune encephalitis from a prospective study.

Yin Y, Wu J, Wu S, Chen S, Cheng W, Li L Eur J Nucl Med Mol Imaging. 2021; 49(6):1918-1929.

PMID: 34939173 PMC: 9016000. DOI: 10.1007/s00259-021-05649-w.

F-fluorodeoxy-glucose positron emission tomography pattern and prognostic predictors in patients with anti-GABAB receptor encephalitis.

Liu X, Yu T, Zhao X, Li G, Lv R, Ai L CNS Neurosci Ther. 2021; 28(2):269-278.

PMID: 34837479 PMC: 8739043. DOI: 10.1111/cns.13767.